New research reveals significant gaps between public perception and scientific evidence for medical cannabis benefits across ...

Marijuana is prescribed to help ease chronic pain and control nausea in cancer patients, but legal red tape has made more ...

Doctors say the studies may make healthcare providers more likely to prescribe federally approved medical cannabis for chronic lower back pain off-label. And consumers can try experimenting with ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

President Donald Trump signed an executive order Thursday to expedite marijuana’s reclassification as a less dangerous drug ...

Medicinal cannabis use has increased rapidly in recent years in Australia. Since access pathways were expanded in 2016, more than 700,000 prescription approvals have been issued. Subscribe to our ...

Barriers to cannabis use still exist across employment policies, housing law, family law, and healthcare policy.

Long Island cannabis dispensaries are peddling the priciest pot in New York — while outselling every other region, according to new state data. Licensed pot shops in Nassau and Suffolk counties ...

Tilray Brands ( TLRY 9.56%) can be a polarizing stock to own. While on the one hand, investors are optimistic about the potential for it to take off if and when the U.S. legalizes marijuana, on the ...

In the future, medicines made from cannabis could help fight ovarian cancer. A research team studying two natural chemicals ...

A survey of college students found associations between simultaneous alcohol and cannabis use and mental health. The researchers concluded that the results offered insights into the connection between ...

The best cannabis stocks to follow Trump’s Schedule III classification are high-quality names with access to the Canadian ...